Risk factors for visual field progression in the low-pressure glaucoma treatment study

American Journal of Ophthalmology

Volumn 154, Issue 4, 2012, Pages 702-711

  De Moraes, Carlos Gustavo ^a,b   Liebmann, Jeffrey M ^a,b   Greenfield, David S ^c   Gardiner, Stuart K ^d   Ritch, Robert ^a,e   Krupin, Theodore ^f,g  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d DEVERS EYE INSTITUTE   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g Chicago Center for Vision Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRIMONIDINE; TIMOLOL; TIMOLOL MALEATE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD PRESSURE FLUCTUATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONJUNCTIVA DISEASE; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DROWSINESS; EYE ALLERGY; FATIGUE; FEMALE; HUMAN; HYPEREMIA; LINEAR REGRESSION ANALYSIS; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERFUSION PRESSURE; PERIMETRY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VISUAL FIELD; XEROSTOMIA;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGED; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GONIOSCOPY; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; QUINOXALINES; RISK FACTORS; TIMOLOL; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84866426613     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.04.015     Document Type: Article

References (43)

1. R.N. Weinreb, P.T. Khaw Primary open-angle glaucoma Lancet 363 9422 2004 1711 1720 (Pubitemid 38670330)
2. H.A. Quigley Glaucoma Lancet 377 9774 2011 1367 1377
3. H. Zhu, D.P. Crabb, M.J. Fredette, D.R. Anderson, D.F. Garway-Heath Quantifying discordance between structure and function measurements in the clinical assessment of glaucoma Arch Ophthalmol 129 9 2011 1167 1174
4. M.O. Gordon, J.A. Beiser, J.D. Brandt The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma Arch Ophthalmol 120 6 2002 714 720 (Pubitemid 34620349)
5. M.C. Leske, A. Heijl, L. Hyman Predictors of long-term progression in the early manifest glaucoma trial Ophthalmology 114 11 2007 1965 1972 (Pubitemid 350016362)
6. AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS): 7 The relationship between control of intraocular pressure and visual field deterioration Am J Ophthalmol 130 4 2000 490 491
7. D.C. Musch, B.W. Gillespie, P.R. Lichter, L.M. Niziol, N.K. Janz CIGTS Study Investigators Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors Ophthalmology 116 2 2009 200 207
8. S. Miglior, V. Torri, T. Zeyen Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study Am J Ophthalmol 144 2 2007 266 275
9. M.B. Shields Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 19 2 2008 85 88 (Pubitemid 351322808)
10. Collaborative Normal-Tension Glaucoma Study Group Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures Am J Ophthalmol 126 4 1998 487 497
11. Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma Am J Ophthalmol 126 4 1998 498 505
12. S. Drance, D.R. Anderson, M. Schulzer Collaborative Normal-Tension Glaucoma Study Group Risk factors for progression of visual field abnormalities in normal-tension glaucoma Am J Ophthalmol 131 6 2001 699 708 (Pubitemid 32522638)
13. T. Krupin, J.M. Liebmann, D.S. Greenfield The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients Ophthalmology 112 3 2005 376 385 (Pubitemid 40312487)
14. D.S. Greenfield, J.M. Liebmann, R. Ritch, T. Krupin Low-Pressure Glaucoma Study Group Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study Ophthalmology 114 3 2007 460 465 (Pubitemid 46282951)
15. T. Krupin, J.M. Liebmann, D.S. Greenfield, R. Ritch, S. Gardiner Low-pressure Glaucoma Study Group A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-pressure Glaucoma Treatment Study Am J Ophthalmol 151 4 2011 671 681
16. F.W. Fitzke, R.A. Hitchings, D. Poinoosawmy, A.I. McNaught, D.P. Crabb Analysis of visual field progression in glaucoma Br J Ophthalmol 80 1 1996 40 48 (Pubitemid 26017558)
17. C.G. De Moraes, V.J. Juthani, J.M. Liebmann Risk factors for visual field progression in treated glaucoma Arch Ophthalmol 129 5 2011 562 568
18. M. Sehi, J.G. Flanagan, L. Zeng, R.J. Cook, G.E. Trope Relative change in diurnal mean ocular perfusion pressure: a risk factor for the diagnosis of primary open-angle glaucoma Invest Ophthalmol Vis Sci 46 2 2005 561 567 (Pubitemid 40270336)
19. J.W. Hardin, J.M. Hilbe Generalized estimating equations 2003 Chapman & Hall/CRC London 1 222
20. D.E. Farrar, R.R. Glauber Multicollinearity in regression analysis: the problem revisited Rev Econ Stat 49 1 1967 92 107
21. B.C. Chauhan, D.F. Garway-Heath, F.J. Goñi Practical recommendations for measuring rates of visual field change in glaucoma Br J Ophthalmol 92 4 2008 569 573 (Pubitemid 351497993)
22. M.J. Doughty, M.L. Zaman Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach Surv Ophthalmol 44 5 2000 367 408 (Pubitemid 30151145)
23. J. Liu, C.J. Roberts Influence of corneal biomechanical properties on intraocular pressure measurement: quantitative analysis J Cataract Refract Surg 31 1 2005 146 155 (Pubitemid 40260702)
24. J.H. Liu, X. Zhang, D.F. Kripke, R.N. Weinreb Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes Invest Ophthalmol Vis Sci 44 4 2003 1586 1590 (Pubitemid 36378585)
25. J. Caprioli, A.L. Coleman Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study Ophthalmology 115 7 2008 1123 1129
26. D. King, S.M. Drance, G. Douglas, M. Schulzer, K. Wijsman Comparison of visual field defects in normal-tension glaucoma and high-tension glaucoma Am J Ophthalmol 101 2 1986 204 207 (Pubitemid 16136578)
27. B.C. Chauhan, S.M. Drance, G.R. Douglas, C.A. Johnson Visual field damage in normal-tension and high-tension glaucoma Am J Ophthalmol 108 6 1989 636 642 (Pubitemid 20013083)
28. K.G. Ahrlich, C.G. De Moraes, C.C. Teng Visual field progression differences between normal-tension and exfoliative high-tension glaucoma Invest Ophthalmol Vis Sci 51 3 2010 1458 1463
29. O. Thonginnetra, V.C. Greenstein, D. Chu, J.M. Liebmann, R. Ritch, D.C. Hood Normal versus high tension glaucoma: a comparison of functional and structural defects J Glaucoma 19 3 2010 151 157
30. W.D. Ramdas, R.C. Wolfs, A. Hofman, P.T. de Jong, J.R. Vingerling, N.M. Jansonius Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study Invest Ophthalmol Vis Sci 52 9 2011 6875 6881
31. K. Mansouri, M.T. Leite, R.N. Weinreb 24-hour ocular perfusion pressure in glaucoma patients Br J Ophthalmol 95 8 2011 1175 1176
32. M.C. Leske, S.Y. Wu, A. Hennis, R. Honkanen, B. Nemesure Barbados Eye Study Group Risk factors for incident open-angle glaucoma: the Barbados Eye Studies Ophthalmology 115 1 2008 85 93 (Pubitemid 350309410)
33. L. Quaranta, F. Gandolfo, R. Turano Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma Invest Ophthalmol Vis Sci 47 7 2006 2917 2923 (Pubitemid 351639767)
34. M.C. Grieshaber, J. Flammer Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance? An exemplary analysis on the basis of two beta-blockers Prog Retin Eye Res 29 1 2010 79 93
35. F.H. Messerli, G. Mancia, C.R. Conti Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144 12 2006 884 893 (Pubitemid 46768128)
36. S. Bangalore, J. Qin, S. Sloan, S.A. Murphy, C.P. Cannon PROVE IT-TIMI 22 Trial Investigators What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial Circulation 122 21 2010 2142 2151
37. National Institute for Health and Clinical Excellence Hypertension: management of hypertension in adults in primary care: pharmacological update NICE Clinical Guideline 34 2006 National Institute for Health and Clinical Excellence London 8
38. L.H. Lindholm, B. Carlberg, O. Samuelsson Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis Lancet 366 9496 2005 1545 1553 (Pubitemid 41540112)
39. C.V. Ram Beta-blockers in hypertension Am J Cardiol 106 12 2010 1819 1825
40. S.S. Hayreh The blood supply of the optic nerve head and the evaluation of it - myth and reality Prog Retin Eye Res 20 5 2001 563 593 (Pubitemid 32695342)
41. S.C. Loon, G. Liew, A. Fung, S.E. Reid, J.C. Craig Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma Clin Experiment Ophthalmol 36 3 2008 281 289 (Pubitemid 351565611)
42. J.H. Liu, F.A. Medeiros, J.R. Slight, R.N. Weinreb Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy Ophthalmology 116 3 2009 449 454
43. J.H. Liu, F.A. Medeiros, J.R. Slight, R.N. Weinreb Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure Ophthalmology 117 11 2010 2075 2079